Spots Global Cancer Trial Database for LUTATHERA Injection General Use Result Survey
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: LUTATHERA Injection General Use Result Survey
Official Title: LUTATHERA Injection General Use Result Survey (Somatostatin Receptor-positive Neuroendocrine Tumor, CAAA601A11401)
Study ID: NCT05844332
Interventions
Study Description
Brief Summary: This study is a multicenter observational study with a central registration system and all-case surveillance system without a control group.
Detailed Description: From the date of the first dose of this drug until 40 weeks after the date of the last dose (64 weeks if 4 doses are administered 8 weeks apart). For patients who discontinue treatment with this drug during the observation period, necessary variables will be examined until 40 weeks after the last dose of this drug during the observation period and recorded in the case report forms (CRF).
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Novartis Investigative Site, Nagoya, Aichi, Japan
Novartis Investigative Site, Hirosaki, Aomori, Japan
Novartis Investigative Site, Kamogawa, Chiba, Japan
Novartis Investigative Site, Kashiwa, Chiba, Japan
Novartis Investigative Site, Toon city, Ehime, Japan
Novartis Investigative Site, Fukuoka city, Fukuoka, Japan
Novartis Investigative Site, Fukushima city, Fukushima, Japan
Novartis Investigative Site, Gifu-city, Gifu, Japan
Novartis Investigative Site, Maebashi city, Gunma, Japan
Novartis Investigative Site, Sapporo city, Hokkaido, Japan
Novartis Investigative Site, Sapporo, Hokkaido, Japan
Novartis Investigative Site, Akashi, Hyogo, Japan
Novartis Investigative Site, Kobe-city, Hyogo, Japan
Novartis Investigative Site, Kobe-shi, Hyogo, Japan
Novartis Investigative Site, Kanazawa-city, Ishikawa, Japan
Novartis Investigative Site, Kita-gun, Kagawa, Japan
Novartis Investigative Site, Kagoshima city, Kagoshima, Japan
Novartis Investigative Site, Kamakura-city, Kanagawa, Japan
Novartis Investigative Site, Yokohama-city, Kanagawa, Japan
Novartis Investigative Site, Kumamoto City, Kumamoto, Japan
Novartis Investigative Site, Sendai city, Miyagi, Japan
Novartis Investigative Site, Suwa, Nagano, Japan
Novartis Investigative Site, Kurashiki-city, Okayama, Japan
Novartis Investigative Site, Okayama-city, Okayama, Japan
Novartis Investigative Site, Osaka Sayama, Osaka, Japan
Novartis Investigative Site, Osaka-city, Osaka, Japan
Novartis Investigative Site, Suita, Osaka, Japan
Novartis Investigative Site, Hamamatsu-city, Shizuoka, Japan
Novartis Investigative Site, Iwata City, Shizuoka, Japan
Novartis Investigative Site, Shizuoka-city, Shizuoka, Japan
Novartis Investigative Site, Sunto Gun, Shizuoka, Japan
Novartis Investigative Site, Bunkyo-ku, Tokyo, Japan
Novartis Investigative Site, Chuo ku, Tokyo, Japan
Novartis Investigative Site, Koto ku, Tokyo, Japan
Novartis Investigative Site, Toyama-city, Toyama, Japan
Novartis Investigative Site, Chuo-city, Yamanashi, Japan
Novartis Investigative Site, Chiba, , Japan
Novartis Investigative Site, Fukui, , Japan
Novartis Investigative Site, Fukuoka, , Japan
Novartis Investigative Site, Hiroshima, , Japan
Novartis Investigative Site, Kyoto, , Japan
Novartis Investigative Site, Niigata, , Japan
Novartis Investigative Site, Osaka, , Japan
Novartis Investigative Site, Osaka, , Japan
Novartis Investigative Site, Tokushima, , Japan
Novartis Investigative Site, Yamagata, , Japan
Contact Details
Name: Novartis Pharmaceuticals
Affiliation: Novartis Pharmaceuticals
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
